1252. A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British C...

por de Wet, Joss, Ban, Joann K, Verdier, Gustavo, Ling, JueJing, Eberg, Maria, Bunko, Andrean, McKimm, Michael
Publicado 2022

319. SWORD 1 and 2: Switch from TDF Containing Regimen to DTG+RPV Maintains Bone Mineral Density and Decreases Bone Turnover Markers Over 148 Weeks

por Kahl, Lesley, McComsey, Grace A, Coronado Poggio, Monica, Lupo, Sergio, de Wet, Joss, Parks, David A, Wynne, Brian, Gartland, Martin, Angelis, Kostas, Aylott, Alicia, Cupo, Michael, Vandermeulen, Kati, van Wyk, Jean A, Smith, Kimberly
Publicado 2019

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-bl...

por Mayer, Kenneth H, Molina, Jean-Michel, Thompson, Melanie A, Anderson, Peter L, Mounzer, Karam C, De Wet, Joss J, DeJesus, Edwin, Jessen, Heiko, Grant, Robert M, Ruane, Peter J, Wong, Pamela, Ebrahimi, Ramin, Zhong, Lijie, Mathias, Anita, Callebaut, Christian, Collins, Sean E, Das, Moupali, McCallister, Scott, Brainard, Diana M, Brinson, Cynthia, Clarke, Amanda, Coll, Pep, Post, Frank A, Hare, C Bradley
Publicado 2020